<?xml version="1.0" encoding="UTF-8"?>
<p id="Par24">1. AMPK activators. Metformin (MET) is a firstline drug for the treatment of type 2 diabetes mellitus and is used often off label to treat several forms of obesity-related disease (e.g., PCOS). Metformin is a potent stimulator of AMPK activation, and as we proved, it reduces sedentariness, increasing the activity in rodents [
 <xref ref-type="bibr" rid="CR38">38</xref>]. This study demonstrated that metformin improves mice physical aerobic performance, ameliorates myotubes formation and prevents oxidative stress damage, modulating ERK and SOD (superoxide dismutases) signaling; therefore, we hypothesized that MET could also act as an antioxidant agent [
 <xref ref-type="bibr" rid="CR37">37</xref>].
</p>
